ARCHIVES

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

This article is from The Cancer Letter archive.

Vol. 14 No. 36 | September 2, 1988

Download PDF Visit The Full Archive

Related Articles

Tight Budget, Turf Battles Kill One Project, Threaten Popular CGP Clinical Trials Effort

July 4, 1986

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

Surgical Oncologists Honor HHS Secretary

March 22, 2002

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

Funding opportunities: ASCO breast cancer research award; Lustgarten Foundation prostate cancer research award; NCI program announcements available.

March 5, 2004

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005